Needham & Company Starts BioTelemetry (BEAT) at Buy
Get Alerts BEAT Hot Sheet
Price: $0.50 --0%
Rating Summary:
8 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 20
Rating Summary:
8 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 20
Join SI Premium – FREE
Needham & Company analyst Mike Matson initiates coverage on BioTelemetry (NASDAQ: BEAT) with a Buy rating and a price target of $52.00.
For an analyst ratings summary and ratings history on BioTelemetry click here. For more ratings news on BioTelemetry click here.
Shares of BioTelemetry closed at $36.67 yesterday.
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Needham Starts Pulse Biosciences (PLSE) at Buy
- HeartBeam Reports Second Quarter 2026 Results
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share